Trastuzumab emtansine (anti-ERBB2) - Primary antibody, specific to ERBB2, Human IgG1, INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor, INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor
Trastuzumab emtansine (anti-ERBB2) - Primary antibody, specific to ERBB2, Human IgG1, INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor, INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor
GRADE & PURITYAnimal Free?Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material.Carrier Free?Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays.Recombinant?Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin.Validated?Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated.ExactAb™?ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications.Low Endotoxin?Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere.Azide Free?Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory.≥90%(SDS-PAGE&SEC-HPLC)See COA
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Descripción general
Trastuzumab emtansine (anti-ERBB2) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine). Trastuzumab emtansine (anti-ERBB2) can be used for the research of advanced breast cancer.
Specifications
Product Name
Trastuzumab emtansine (anti-ERBB2) - Primary antibody, specific to ERBB2, Human IgG1, INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor
INHIBITOR of Receptor protein-tyrosine kinase erbB-2 inhibitor
Isotipo
Human IgG1
Tipo de cadena ligera
kappa
SDS-PAGE
145 kDa
Método de purificación
Protein A purified
Concentración
See COA
CAS
1018448-65-1
Almacenamiento y envío
Forma
Liquid
Condiciones de almacenamiento de almacenamiento
Store at -80°C,Avoid repeated freezing and thawing
Enviado en
Dry ice packs + Cold packs
Estabilidad y almacenamiento
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Imágenes
Trastuzumab emtansine (anti-ERBB2) (Ab175686) - Flow Cytometry Flow Cytometry analysis of MCF7 cells labelling ERBB2 (red) with Trastuzumab emtansine (anti-ERBB2) (Ab175686) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Trastuzumab emtansine (anti-ERBB2) (Ab175686) - ELISA Immobilized Recombinant Human ErbB2/HER2 protein (rp169607) at 1.0 μg/mL can bind Trastuzumab emtansine (anti-ERBB2) (Ab175686) with the EC₅₀ of 138.5 ng/mL.
Trastuzumab emtansine (anti-ERBB2) (Ab175686) - SEC The purity of Trastuzumab emtansine (anti-ERBB2) (Ab175686) is more than 95% verified by HPLC.
Trastuzumab emtansine (anti-ERBB2) (Ab175686) - SEC-MS The drug-to-antibody ratio (DAR) of the Trastuzumab emtansine (anti-ERBB2) (Ab175686) is 3.3.
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
